Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 36, 2017 - Issue 2
Submit an article Journal homepage
483
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease

Amir A. AzariThomas Jefferson School of Medicine, Wills Eye Hospital, Philadelphia, PA, USA,
,
Remzi KaradagThomas Jefferson School of Medicine, Wills Eye Hospital, Philadelphia, PA, USA, ;School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey, Correspondence[email protected]
,
Mozhgan Rezaei KanaviOcular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,
,
Sarah NehlsSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA, and
,
Neal BarneySchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA, and
,
Kyungmann KimDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA
,
Walter LongoSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA, and
,
Peiman HemattiSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA, and
&
Mark JuckettSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA, and
show all
Pages 152-156 | Received 07 Jun 2016, Accepted 02 Jul 2016, Published online: 22 Jul 2016

References

  • Socié G, Ritz J, Martin PJ. Current challenges in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010;16:146–151
  • Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100:415–419
  • Hessen M, Akpek EK. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 2012;12:540–547
  • Westeneng AC, Hettinga Y, Lokhorst H, et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010;29:758–763
  • Couriel DR. Ancillary and supportive care in chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008;21:291–307
  • Ralph RA, Doane MG, Dohlman CH. Clinical experience with a mobile ocular perfusion pump. Arch Ophthalmol 1975;93:1039–1043
  • Noble BA, Loh RS, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652
  • Dalmon CA, Chandra NS, Jeng BH. Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit. Arch Ophthalmol 2012;130:1612–1613
  • Urzua CA, Vasquez DH, Huidobro A, et al. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 2012;37:684–688
  • Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802–806
  • Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139:242–246
  • Lee GA, Chen SX. Autologous serum in the management of recalcitrant dry eye syndrome. Clin Experiment Ophthalmol 2008;36:119–122
  • Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188–1197
  • Jeng BH. Use of autologous serum in the treatment of ocular surface disorders. Arch Ophthalmol 2011;129:1610–1612
  • Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984–1989
  • Mukerji N, Sinha R, Vajpayee RB. Role of autologous serum in persistent epithelial defects. Br J Ophthalmol 2002;86:832
  • Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond) 2004;18:609–614
  • Jeng BH, Dupps WJ. Jr Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 2009;28:1104–1108
  • Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115–1120
  • del Castillo JM, de la Casa JM, Sardiña RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea 2002;2:781–783
  • Ziakas NG, Boboridis KG, Terzidou C, et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions. Clin Experiment Ophthalmol 2010;38:683–687
  • Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001;20:807–810
  • Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003;31:579–583
  • Rocha EM, Pelegrino FS, de Paiva CS, et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000;25:1101–1103
  • Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467–1474
  • Terry RL, Schnider CM, Holden BA, et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci 1993;70:234–243
  • Rosser DA, Cousens SN, Murdoch IE, et al. How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 2003;44:3278–3281
  • Mitchell BM, Wilhelmus KR. Inflammatory response to fungal keratitis. Ocul Surf 2005;3:152–153

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.